Molecular characterization of an EWSR1-POU5F1 fusion associated with a t(6;22) in an undifferentiated soft tissue sarcoma

Cancer Genetics

Volumn 204, Issue 8, 2011, Pages 423-429

  Deng, Fang Ming ^a   Galvan, Karen ^a   de la Roza, Gustavo ^a   Zhang, Shengle ^a   Souid, Abdul Kader ^a   Stein, Constance K ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Chromosome 22; Chromosome 6; EWSR1; POU5F1; Soft tissue sarcoma

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; PROTEIN S 100; VIMENTIN; CALMODULIN BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; ONCOPROTEIN; POU5F1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CHILD; CHIMERA; CHROMOSOME 12Q; CHROMOSOME 22P; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 6; CLINICAL FEATURE; CONTINUOUS INFUSION; DNA BINDING MOTIF; DRUG EFFECT; EWSR1 GENE; FEMALE; FUSION GENE; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MICROMORPHOLOGY; MOLECULAR PATHOLOGY; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; POU5F1 GENE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SCHOOL CHILD; SOFT TISSUE SARCOMA; TRANSCRIPTION INITIATION; TREATMENT DURATION; TUMOR VOLUME; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CHROMOSOME 22; CHROMOSOME 6; ENZYME IMMUNOASSAY; GENE TRANSLOCATION; GENETICS; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; SARCOMA;

AMINO ACID SEQUENCE; BASE SEQUENCE; CALMODULIN-BINDING PROTEINS; CELL DIFFERENTIATION; CHILD; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 6; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MAGNETIC RESONANCE IMAGING; MOLECULAR SEQUENCE DATA; OCTAMER TRANSCRIPTION FACTOR-3; ONCOGENE PROTEINS, FUSION; PROGNOSIS; RNA-BINDING PROTEINS; SARCOMA; TRANSLOCATION, GENETIC;

EID: 84856389700     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.05.006     Document Type: Article

References (14)

1. Arvand A., Denny C.T. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 2001, 20:5747-5754.
2. de Alava E., Gerald W.L. Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 2000, 18:204-213.
3. Bennicelli J.L., Barr F.G. Chromosomal translocations and sarcomas. Curr Opin Oncol 2002, 14:412-419.
4. Hornick J.L., Fletcher C.D.M. Myoepithelial tumors of soft tissue-a clinicopathologic and immunohistochemial study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol 2003, 27:1183-1196.
5. Yamaguchi S., Yamazaki Y., Ishikawa Y., et al. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Genes Chromosomes Cancer 2005, 43:217-222.
6. Gleason B.G., Fletcher C.D.M. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol 2007, 31:1813-1824.
7. Möller E., Stenman G., Mandahl N., et al. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 2008, 215:78-86.
8. Antonescu C.R., Zhang L., Chang N.E., et al. Novel EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of 29 cases, including soft tissue, bone and visceral locations showing common involvement of EWSR1 gene rearrangement. Mod Pathol 2010, 23:14A-15A.
9. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24:372-376.
10. Hochedlinger K., Yamada Y., Beard C., et al. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005, 121:465-477.
11. Atlasi Y., Mowla S.J., Ziaee S.A., et al. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 2007, 120:1598-1602.
12. Stoop H., Honecker F., van de Geijn G.J., et al. Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol 2008, 216:43-54.
13. Lee J., Kim J.Y., Kang I.Y., et al. The EWS-Oct-4 fusion gene encodes a transforming gene. Biochem J 2007, 406:519-526.
14. Makino H., Toyoda M., Matsumoto K., et al. Mesenchymal to embryonic incomplete transition of human cells by chimeric OCT4/3 (POU5F1) with physiological co-activator EWS. Exp Cell Res 2009, 315:2727-2740.